Pharmaceutical Excipients Market – Forthcoming Trends to Boost the Global Industry Revenue

Recent Developments in the Global Pharmaceutical Excipients Manufacturing Market:

 In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.

In February 2019, Associated British Foods plc (UK) signed an agreement with Indchem International (India) under which, Indchem will distribute Associated British Food’s functional lipid excipient product line in the Indian market.

In January 2019, Croda International (UK) acquired Brenntag Biosector (Denmark) for its vaccine adjuvants portfolio which would be complementary to Croda’s pharmaceutical excipients portfolio.

In December 2018, Roquette Feres (France) signed an agreement with Thermo Fisher Scientific (US), which gives Thermo Fisher the right to distribute the product portfolio of Roquette in the US and Canada.

Expected Revenue Growth:

The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%.

Download PDF Brochure@

Key Questions Addressed in the Report:

Who are the top 10 players operating in the pharmaceutical excipients market?
What are the drivers, restraints, opportunities, and challenges in the pharmaceutical excipients market?
What are the industry trends as well as the current scenario in the pharmaceutical excipients market?
What are the growth trends in the pharmaceutical excipients market at the segmental and overall market levels?
How is the pharmaceutical excipients market performing in different regions across the globe?

Market Share Estimation:

The market shares for leading pharmaceutical excipients manufacturing companies was arrived at after detailed assessment of their revenues from the pharmaceutical excipients business by secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases revenue share was arrived at after detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with various industry experts.

The Asia Pacific is expected to be the fastest growing the market in 2019

In 2018, the Asia Pacific region was seen as the fastest growing region in the Pharmaceutical Excipients Manufacturing Market. The ease of doing business in the Asia Pacific region in terms of reduced regulatory stringency, reduced raw material & labor costs, and a higher target market make this region the fastest growing market in 2019.

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides.

Request Sample Pages@

Global Leaders:

DuPont de Nemours, Inc. (US) and Roquette Feres (France) dominated the global pharmaceutical excipients market in 2018. The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (UK), Archer Daniels Midland Company (US), Lubrizol Corporation(US), and Croda International (UK). Other players in this market are Innophos Holdings (US), Kerry Group plc (Ireland), WACKER Chemie AG (Germany), Colorcon, Inc. (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France).